Available Online: Biodefense and Infectious Diseases Funding Opportunities Webinar

The National Institute of Allergies and Infectious Diseases (NIAID) awards close to $6,000,000,000 annually. Taking into account activities by DTRA, DARPA, US Army, BARDA, etc., this is a funding force no one in the field can afford to ignore.

In this webinar, we introduce you to Biodefense and Infectious Diseases sources of funding such as NIAID, DTRA, DARPA, US Army, and BARDA, and give examples of current open solicitations. We discuss the process for applying, major challenges, and how to maximize your chances for award.

 

View Slide Deck

/0 Comments/by
You might also like
The Advanced Research Projects Agency for Health. What is it? What will it fund?ARPA-H: What R&D will be funded by the “DARPA for Health”?
National Heart, Lung, and Blood Institute Presentation at the 18th Non-Dilutive Funding Summit, 2023, with Dr. Kathleen RouscheNHLBI at NDFS 2023, with Dr. Kathleen Rousche
Diassess Awarded Up to $21.9M from BARDA
AN INTRO TO SBIR
NIAID BAA January 2022
How Non-Dilutive Funding Can Extend Runway in BioPharma, Biotech, and Tech BioIs Non-Dilutive Funding the Key to Extending Runway in Biopharma and Biotech?
Dr. Mike Minnicozzi will speak at the 18th Annual Non-Dilutive Funding Summit, in San Franciso, at the Marines' Memorial Club and Hotel Union Square, on January 11, 2023. He is a senior Program Officer for the National Institute of Allergy and Infectious Diseases (NIAID), NIH. In his current position, Mike works in the Division of Allergy, Immunology and Transplantation (DAIT) where he administers and oversees a research portfolio of grants, cooperative awards and contracts, on topics such as Allergy, Asthma, Atopic Dermatitis and Sepsis.NIAID to Speak at the Non-Dilutive Funding Summit 2023
AN INTRO TO SBIR
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *